Company Overview
American HealthCare Capital is pleased to exclusively introduce an Orthotics & Prosthetics (O&P) company for sale in the Midwest. The company has been in business since 1983 and has four office locations and a central fabrication lab with satellite locations. It provides comprehensive, custom O&P care for patients with custom orthoses for upper and lower extremities and prosthetics for both adults and children, utilizing the most advanced technology for its products and services.
Core Competencies and Differentiators
• More than 40 years of orthotic and prosthetic experience, operating since 1983.
• Comprehensive Orthotic and Prosthetic capabilities for upper and lower extremities.
• Pediatric custom orthotic and prosthetic services
• ABC (American Board of Certification) Accredited Facilities
• In-House Fabrication Lab with state-of-the-art technology, fully staffed
• Established deep referral relationships within the medical community, including hospitals, physicians, orthopedic practices, and rehabilitation providers.
• Market dominance operating footprint — The combination of primary operating facilities and smaller clinical locations provides strong market access to referral sources.
• Experienced operating platform with established personnel, facilities, systems, and clinical resources.
• Certified CPOs (Certified Prosthetist Orthotist), COs (Certified Orthotist), CPs (Certified Prosthetists), C. Peds (Certified Pedorthist), COAs (Certified O&P Assistant)
Product Mix
The Company’s product mix is 92% Orthotics and 8% Prosthetics.
Financial Overview
The Company’s revenues have been consistently at $8.5 million for the past three years, from 2023 to 2025. For the six months ended June 2026, the company’s revenues were $4.0 million, and they are forecasting $8.1 million for 2026. The gross profit has steadily increased over the three years from 74% to 77%. The backlog is very strong at over $1.8 million in gross billings, and new patients versus existing patients exceed 66% of total patient visits. The company’s in-depth infrastructure utilizes over 60 highly qualified staff members, with over 16 practitioners who are CPOs, COs, CPs, C.Peds, and COAs.
Strategic Synergies
The company is seeking a strategic investor who can benefit from the following synergies:
• Utilize strategic investors’ National Insurance Network Contracts, resulting in higher pricing. The margins should increase by at least 10% with preferred national contract rates, and with no change in internal costs, the increased revenues will flow to the bottom line.
• Strategic Investors with centralized billing functions will be able to reduce the billing functions by 50 to 60% through higher efficiency.
• The company is servicing patients with many products and services. Some of these products have very low reimbursement rates and consume a significant amount of time and labor in the fabrication Lab. Lower-margin products and services could be curtailed, with a much stronger focus on profitability. By implementing a profitability Improvement Program, the lower-margin products will be reduced with corresponding costs, resulting in higher overall profits.
• This O&P company’s product mix is 92% Orthotics and only 8% Prosthetics. The company needs assistance to increase its Prosthetic revenues to at least 20% of total revenues. This shift will generate higher margins with increased profitability.
• A well-positioned strategic partner can leverage the company’s infrastructure, referrals, and market dominance in its metro area. The company has multiple locations with significant referral partners and has been servicing patients for multiple decades.
Asking Price
The final purchase price for this multi-location orthotics and prosthetics opportunity is to be determined through discussions with qualified strategic buyers. This does not include cash, receivables, or working capital.